{msg=success, data={columnId=128, navBreadcrumb=[{brother=[], entityTag=, id=null, name=About Us, type=false, url=/column/80/}, {brother=[], entityTag=, id=null, name=Member Unit, type=false, url=/column/125/}, {brother=[], entityTag=, id=null, name=Medicine sector, type=false, url=/column/128/}, {brother=[], entityTag=, id=null, name=Northeast Pharm, type=false, url=}], list=[{columnId=126, name=Carbon Sector, linkUrl=/column/126/}, {columnId=127, name=Steel Sector, linkUrl=/column/127/}, {columnId=128, name=Medicine sector, linkUrl=/column/128/}, {columnId=129, name=Commerce sector, linkUrl=/column/129/}, {columnId=131, name=Aviation sector, linkUrl=/column/131/}, {columnId=130, name=Fangda Real Estate Group, linkUrl=/column/130/}], homePage={brother=[], entityTag=, id=null, name=新首页, type=false, url=/}}, status=101}
Northeast Pharm

Northeast Pharm Group Co., Ltd (hereinafter referred to as "NEPG", stock code: 000597) is a listed company of Liaoning Fangda Group Industry Co., Ltd. The company, formerly known as the Northeast General Pharmaceutical Factory, was founded in 1946. It has provided assistance in construction of 52 pharmaceutical companies in 19 cities and provinces and cultivated more than 1300 cadres to the country. It is known as the cradle of China's national pharmaceutical industry. 

At present,NEPG has major business sectors such as APIactive pharmaceutical ingredient,chemical preparation, pharmaceutical commerce,pharmaceutical engineering and biomedicine, covering the entire pharmaceutical research and development, manufacturing, distribution of the entire industrial chain, with nearly 8,000 employees, total assets of 12 billion RMB.  The company mainly produces vitamin series drugs, anti-infective systemic drugs, obstetrics and gynecology systematic drugs, digestive system drugs, urinary system drugs, antiviral series drugs, cardiovascular and cerebrovascular drugs, analgesia cough series drugs, biological diagnosis series, comprehensive health field series and other ten series of high-quality products. There are more than 400 kinds of APIs, pharmaceutical intermediates and preparation products, the leading products are exported to more than 100 countries and regions.

The company has a strong product manufacturing system.  The preparation production base covers an area of 180,000 square meters and has more than 30 production lines annual production capacity of 10 billion tablets ( pills, tablets, bottles). The API production base covers an area of 910000 square meters, which is the national demonstration plant for intelligent manufacturing of bulk APIs and pharmaceutical intermediates, the main products including vitamin C series, L-carnitine series, the Fosfomycin series, piracetam, carprost methyl ester, amantadine, Sucralfate, berberine, chloramphenicol,etc. It also extends to the downstream pharmaceutical industry chain in NEPG, forming comprehensive competitive advantages that are difficult to be duplicated.

NEPG is a national green factory, with the most advanced environmental protection treatment system in China, to achieve comprehensive treatment of sewage, tail gas, noise and solid waste. The treatment capacity of the raw material sewage treatment system reaches 50,000 cubic meters per day, leading the industry in technical level.

 The incinerator can process 9000 tons of hazardous waste every year, and the exhaust emissions meet the EU standard.  The circular economy industrial park has realized the recycling treatment of production waste and turned it into treasure.

NEPG has a sound quality management system, and the product quality meets the latest quality standards of GMP, EP, USP, JP, BP, CP and so on.  Many products have passed EDQM, FDA, Japanese Ministry of Health and Welfare, BRC, HALAL, KOSHER and other international high-end certification.  The leading products have passed the registration and quality audit in the United States, Europe, Japan, Brazil, Russia, Poland and other countries and regions.

Enterprise official website linkhttp://www.nepharm.com.cn/